Screening key biomarkers in Budd-Chiari syndrome-associated hepatocellular carcinoma patients

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000032569

Enrollment

Unknown

Registered

2020-05-02

Start date

2020-05-07

Completion date

Unknown

Last updated

2020-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Budd-Chiari syndrome hepatocellular carcinoma

Interventions

Budd-Chiari syndrome-associated hepatocellular carcinoma group VS Budd-Chiari syndrome without hepatocellular carcinoma group:N/A

Eligibility

Sex/Gender

All

Age

20 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. There is definite imaging evidence that the patient has Budd Chiari syndrome; 2. There is obvious pathological evidence that the patient has HCC.

Exclusion criteria

Exclusion criteria: 1. Patients with other cancer diseases; 2. Patients have secondary Budd Chiari syndrome.

Design outcomes

Primary

Measure	Time frame
Differences genes;	—

Countries

Cina

Contacts

Public ContactQiang Tang

Hepatobiliary Surgery of Henan People's Hospital

jaketq@163.com+86 15939011212

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026